Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNA-sequencing of gastric tissues derived from three inflamed-type and three desert-type tumors

ABSTRACT: scRNA-sequencing of gastric tissues derived from three inflamed-type and three desert-type tumors

PROVIDER: PRJNA1221573 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR32283700_1.fastq.gz	Fastqsanger.gz
	SRR32283700_2.fastq.gz	Fastqsanger.gz
	SRR32283701_1.fastq.gz	Fastqsanger.gz
	SRR32283701_2.fastq.gz	Fastqsanger.gz
	SRR32283702_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 68

Similar Datasets

scRNA-sequencing of gastric tissues derived from eight inflamed-type and eight desert-type tumors

Project description:This study reports single-cell RNA sequencing (scRNA-seq) data from 16 human gastric cancer tumor samples. The cohort includes 8 immune-inflamed-type and 8 immune-desert-type tumors, aiming to characterize the cellular and transcriptomic landscapes associated with distinct immune phenotypes in gastric cancer. The dataset provides high-resolution profiles of tumor and immune cell states, enabling the investigation of epithelial-intrinsic regulators and cell-type-specific programs regulating immune desertification.

2026-07-31 | GSE341101 | GEO

scRNA-sequencing of gastric tissues derived from eight inflamed-type and eight desert-type tumors

Project description:scRNA-sequencing of gastric tissues derived from eight inflamed-type and eight desert-type tumors

| PRJNA1499457 | ENA

RNA-sequencing of gastric tissues derived from five inflamed-type and five desert-type tumors

Project description:RNA-sequencing of gastric tissues derived from five inflamed-type and five desert-type tumors

| PRJNA1220931 | ENA

scRNA-sequencing of gastric tissues derived from three inflamed-type and three desert-type tumors

Project description:Transforming gastric tumors from immunosuppressive to immunostimulatory is a potential approach to enhance immune checkpoint blockade response. Here, we developed a chromosomal instability subtype gastric cancer mouse model with an immunoactive tumor microenvironment (TME) and a stem cell-originated mouse-derived allograft model with an immunosuppressed TME to investigate mechanisms regulating the tumor immunophenotype and uncover therapeutic strategies to remodel the TME.

2025-02-18 | GSE289116 | GEO

RNA-sequencing of gastric tissues derived from five inflamed-type and five desert-type tumors

2025-02-18 | GSE289066 | GEO

DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden

Project description:High tumor mutational burden (TMB) is a predictive biomarker for the responsiveness of cancer to immune checkpoint inhibitor therapy that indicates whether immune cells can sufficiently recognize cancer cells as non-self. However, about 30% of all cancers from The Cancer Genome Atlas are classified as immune-desert tumors lacking T cell infiltration despite high TMB. Since the underlying mechanism of these immune-desert tumors has yet to be unraveled, there is a pressing need to transform such immune-desert tumors into immune-inflamed tumors and thereby enhance their responsiveness to anti-PD1 therapy. Here, we present a systems framework for identifying immuno-oncotargets, based on analysis of gene regulatory networks, and validating the effect of these targets in transforming immune-desert into immune-inflamed tumors. In particular, we identify DEAD-box helicases 54 (DDX54) as a master regulator of immune escape in immune-desert lung cancer with high TMB, and show that knockdown of DDX54 can increase immune cell infiltration and lead to improved sensitivity to anti-PD1 therapy.

2025-03-19 | GSE289119 | GEO

DDX54 downregulation enhances anti-PD1 therapy in immune-desert lung tumors with high tumor mutational burden

2025-03-19 | GSE268555 | GEO